Is QPTFF or SBUX a better dividend investment in 2026?

QPTFF currently yields 6578.95% with a 5% 5-year dividend growth rate. SBUX yields 2.75% with 5% growth. The better choice depends on your goal: QPTFF offers higher current income.

What is the dividend yield difference between QPTFF and SBUX?

QPTFF has a forward dividend yield of 6578.95% ($2.00/share annually). SBUX yields 2.75% ($2.46/share annually). The yield gap is 6576.20 percentage points.

Home › Compare › QPTFF vs SBUX

QPTFF vs SBUX: Dividend Comparison 2026

QPTFF yields 6578.95% · SBUX yields 2.75%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 QPTFF wins by $903160944306728.00M in total portfolio value

INVESTMENT

TIME HORIZON10 years

QPTFF

● Live price

6578.95%

Share price

$0.03

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$903160944306728.13M

Annual income

$876,939,829,008,324,100,000.00

Full QPTFF calculator →

SBUX

● Live price

2.75%

Share price

$89.59

Annual div

$2.46

5Y div CAGR

48.3%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$157.5K

Annual income

$65,840.13

Full SBUX calculator →

Portfolio growth — QPTFF vs SBUX

📍 QPTFF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	QPTFF	SBUX
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, QPTFF + SBUX cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

QPTFF pays

SBUX pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

QPTFF

Annual income on $10K today (after 15% tax)

$559,210.53/yr

After 10yr DRIP, annual income (after tax)

$745,398,854,657,075,400,000.00/yr

SBUX

Annual income on $10K today (after 15% tax)

$233.40/yr

After 10yr DRIP, annual income (after tax)

$55,964.11/yr

At 15% tax rate, QPTFF beats the other by $745,398,854,657,075,400,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of QPTFF + SBUX for your $10,000?

QPTFF: 50%SBUX: 50%

100% SBUX50/50100% QPTFF

Portfolio after 10yr

$451580472153364.13M

Annual income

$438,469,914,504,162,100,000.00/yr

Blended yield

97.10%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on SBUX right now

QPTFF

No analyst data

Altman Z

2.1

Piotroski

1/9

SBUX

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$104.00

+16.1% upside vs current

Range: $90.00 — $120.00

Altman Z

2.6

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

QPTFF buys

SBUX buys

Politician	Chamber	Ticker	Type	Amount	Date
Shelley Moore Capito	🏛 Senate	$SBUX	▼ Sell	$1,001 - $15,000	2026-01-28
Shelley Moore Capito	🏛 Senate	$SBUX	▼ Sell	$1,001 - $15,000	2026-01-28
Sheldon Whitehouse	🏛 Senate	$SBUX	▼ Sell	$1,001 - $15,000	2026-01-09
Sheldon Whitehouse	🏛 Senate	$SBUX	▼ Sell	$1,001 - $15,000	2026-01-09
Sheldon Whitehouse	🏛 Senate	$SBUX	▼ Sell	$1,001 - $15,000	2026-01-09
Sheldon Whitehouse	🏛 Senate	$SBUX	▼ Sell	$1,001 - $15,000	2026-01-09
Dan Newhouse	🏢 House	$SBUX	▼ Sell	$1,001 - $15,000	2025-12-11
Ro Khanna	🏢 House	$SBUX	▼ Sell	$15,001 - $50,000	2025-10-07
Ro Khanna	🏢 House	$SBUX	▲ Buy	$15,001 - $50,000	2025-09-29
Ro Khanna	🏢 House	$SBUX	▼ Sell	$15,001 - $50,000	2025-08-26

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricQPTFFSBUX

Forward yield	6578.95% ✓	2.75%
Annual dividend / share	$2.00	$2.46 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	48.3% ✓
Portfolio after 10y	$903160944306728.13M ✓	$157.5K
Annual income after 10y	$876,939,829,008,324,100,000.00 ✓	$65,840.13
Total dividends collected	$901400901751488.63M ✓	$127.5K
Payment frequency	quarterly	quarterly
Sector	Stock	Consumer Discretionary

Year-by-year: QPTFF vs SBUX ($10,000, DRIP)

Year	QPTFF Portfolio	QPTFF Income/yr	SBUX Portfolio	SBUX Income/yr	Gap
1← crossover	$668,595	$657,894.74	$11,107	$407.21	+$657.5K → QPTFF
2	$41,824,271	$41,108,874.62	$12,512	$626.87	+$41.81M → QPTFF
3	$2,448,103,158	$2,403,351,188.44	$14,366	$978.69	+$2448.09M → QPTFF
4	$134,091,931,604	$131,472,461,224.39	$16,929	$1,557.50	+$134091.91M → QPTFF
5	$6,873,616,037,527	$6,730,137,670,710.89	$20,658	$2,543.80	+$6873616.02M → QPTFF
6	$329,775,376,912,396	$322,420,607,752,241.75	$26,406	$4,302.22	+$329775376.89M → QPTFF
7	$14,809,652,943,541,940	$14,456,793,290,245,678.00	$35,877	$7,622.00	+$14809652943.51M → QPTFF
8	$622,603,404,175,321,200	$606,757,075,525,731,300.00	$52,741	$14,352.64	+$622603404175.27M → QPTFF
9	$24,505,715,232,153,338,000	$23,839,529,589,685,744,000.00	$85,676	$29,243.03	+$24505715232153.25M → QPTFF
10	$903,160,944,306,728,100,000	$876,939,829,008,324,100,000.00	$157,513	$65,840.13	+$903160944306728.00M → QPTFF

QPTFF vs SBUX: Complete Analysis 2026

QPTFF — Stock

Quest PharmaTech Inc., a pharmaceutical company, develops antibody based immunotherapeutic products for cancer. Its lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC16, for targeted cancer therapy applications. The company also offers Oregovomab, an anti-CA-125 antibody, which has completed Phase II clinical trial for the treatment of ovarian cancer. In addition, it develops, manufactures, and commercializes immunotherapy products for pancreatic cancer. Further, the company develops products by using proprietary transdermal delivery technologies for dermatology and wound healing applications; skin penetrating active molecules for cosmetic and pharmaceutical use; and combinatorial immunotherapeutic products for the treatment cancer by using monoclonal antibodies of the immunoglobulin of G and E class. Quest PharmaTech Inc. is headquartered in Edmonton, Canada.

Full QPTFF Calculator →

SBUX — Consumer Discretionary

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates through three segments: North America, International, and Channel Development. Its stores offer coffee and tea beverages, roasted whole beans and ground coffees, single serve products, and ready-to-drink beverages; and various food products, such as pastries, breakfast sandwiches, and lunch items. The company also licenses its trademarks through licensed stores, and grocery and foodservice accounts. The company offers its products under the Starbucks, Teavana, Seattle's Best Coffee, Evolution Fresh, Ethos, Starbucks Reserve, and Princi brands. As of October 3, 2021, it operated 16,826 company-operated and licensed stores in North America; and 17,007 company-operated and licensed stores internationally. The company was founded in 1971 and is based in Seattle, Washington.

Full SBUX Calculator →

📬

Get this QPTFF vs SBUX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

QPTFF vs SCHD QPTFF vs JEPI QPTFF vs O QPTFF vs KO QPTFF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.